Literature DB >> 18815731

Degradable and bioresorbable polymers in surgery and in pharmacology: beliefs and facts.

Michel Vert1.   

Abstract

The number of articles dealing with degradable polymers and macromolecules is increasing rapidly and the number of proposed compounds as well. However, not all have a high potential for effective applications. This contribution examines first the criteria to be taken into account when commercialisation of polymeric compounds and devices aimed at helping the body for a limited period of time, i.e. the healing time, is the main goal. What is really known is tentatively analysed by considering some of the candidates present in literature confronted to the targeted potential applications. Tentative comments are made on what should be done to qualify a candidate. Last but not least, trends in the search for polymers to be exploited in presently attracting areas such as bioresorbable stents, hydrogels to deliver bioactive macromolecules like proteins and polynucleotides or polyelectrolytes to temporarily complex charged biomacromolecules like proteins or genes are considered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815731     DOI: 10.1007/s10856-008-3581-4

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  35 in total

1.  Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA.

Authors:  S C Richardson; H V Kolbe; R Duncan
Journal:  Int J Pharm       Date:  1999-02-15       Impact factor: 5.875

2.  PLA stereocopolymers as sources of bioresorbable stents: preliminary investigation in rabbit.

Authors:  Antoine Lafont; Suming Li; Henri Garreau; Frederic Cornhill; Michel Vert
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2006-05       Impact factor: 3.368

Review 3.  Therapeutic applications of implantable drug delivery systems.

Authors:  A K Dash; G C Cudworth
Journal:  J Pharmacol Toxicol Methods       Date:  1998-07       Impact factor: 1.950

Review 4.  Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease.

Authors:  Joachim Kohn; Joan Zeltinger
Journal:  Expert Rev Med Devices       Date:  2005-11       Impact factor: 3.166

5.  In vitro degradation rates of partially N-acetylated chitosans in human serum.

Authors:  K M Vårum; M M Myhr; R J Hjerde; O Smidsrød
Journal:  Carbohydr Res       Date:  1997-03-26       Impact factor: 2.104

6.  Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans.

Authors:  H Tamai; K Igaki; E Kyo; K Kosuga; A Kawashima; S Matsui; H Komori; T Tsuji; S Motohara; H Uehata
Journal:  Circulation       Date:  2000-07-25       Impact factor: 29.690

7.  Synthetic biodegradable polymers as orthopedic devices.

Authors:  J C Middleton; A J Tipton
Journal:  Biomaterials       Date:  2000-12       Impact factor: 12.479

8.  A physico-chemical approach of polyanion-polycation interactions aimed at better understanding the in vivo behaviour of polyelectrolyte-based drug delivery and gene transfection.

Authors:  Laurent Leclercq; Mahfoud Boustta; Michel Vert
Journal:  J Drug Target       Date:  2003-04       Impact factor: 5.121

9.  On the biodegradation of poly-beta-hydroxybutyrate (PHB) homopolymer and poly-beta-hydroxybutyrate-hydroxyvalerate copolymers.

Authors:  N D Miller; D F Williams
Journal:  Biomaterials       Date:  1987-03       Impact factor: 12.479

10.  Growth of various cell types in the presence of lactic and glycolic acids: the adverse effect of glycolic acid released from PLAGA copolymer on keratinocyte proliferation.

Authors:  Xavier Garric; Jean-Pierre Molès; Henri Garreau; Christian Braud; Jean-Jacques Guilhou; Michel Vert
Journal:  J Biomater Sci Polym Ed       Date:  2002       Impact factor: 3.517

View more
  13 in total

1.  Poly(ε-caprolactone) and poly(D,L-lactic acid-co-glycolic acid) scaffolds used in bone tissue engineering prepared by melt compression-particulate leaching method.

Authors:  Samuel H Barbanti; Arnaldo R Santos; Cecília A C Zavaglia; Eliana A R Duek
Journal:  J Mater Sci Mater Med       Date:  2011-07-21       Impact factor: 3.896

2.  Correlation of hydrolytic degradation with structure for copolyesters produced from glycolic and adipic acids.

Authors:  J Simitzis; D Triantou; S Soulis; K Triantou; Ch Simitzis; L Zoumpoulakis
Journal:  J Mater Sci Mater Med       Date:  2009-12-12       Impact factor: 3.896

3.  Isovolemic Degradation of Polycaprolactone Particles and Calculation of Their Original Size from Human Biopsy.

Authors:  JongSeo Kim
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-06-26

4.  New class of biodegradable polymers formed from reactions of an inorganic functional group.

Authors:  Jun Yoo; Denison J Kuruvilla; Sheetal R D'Mello; Aliasger K Salem; Ned B Bowden
Journal:  Macromolecules       Date:  2012-02-21       Impact factor: 6.057

5.  Antifungal efficacy of itraconazole-loaded TPGS-b-(PCL-ran-PGA) nanoparticles.

Authors:  Lixin Qiu; Bicheng Hu; Hongbo Chen; Shanshan Li; Yuqian Hu; Yi Zheng; Xinxing Wu
Journal:  Int J Nanomedicine       Date:  2015-02-17

Review 6.  Biodegradable Materials and Metallic Implants-A Review.

Authors:  Mythili Prakasam; Janis Locs; Kristine Salma-Ancane; Dagnija Loca; Alain Largeteau; Liga Berzina-Cimdina
Journal:  J Funct Biomater       Date:  2017-09-26

7.  A Role for CD154, the CD40 Ligand, in Granulomatous Inflammation.

Authors:  Julien Villeneuve; Alexis Desmoulière; Antoine Dewitte; Nelly Bordeau; Pierre Costet; Laia Bassaganyas; Jean-Christophe Fricain; Jean Ripoche; Sébastien Lepreux
Journal:  Mediators Inflamm       Date:  2017-07-12       Impact factor: 4.711

8.  Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy.

Authors:  Tiejun Zhao; Hezhong Chen; Yuchao Dong; Jiajun Zhang; Haidong Huang; Ji Zhu; Wei Zhang
Journal:  Int J Nanomedicine       Date:  2013-05-16

9.  Robust aptamer-polydopamine-functionalized M-PLGA-TPGS nanoparticles for targeted delivery of docetaxel and enhanced cervical cancer therapy.

Authors:  Guojun Xu; Xinghua Yu; Jinxie Zhang; Yingchao Sheng; Gan Liu; Wei Tao; Lin Mei
Journal:  Int J Nanomedicine       Date:  2016-06-22

10.  Morphogenetically-Active Barrier Membrane for Guided Bone Regeneration, Based on Amorphous Polyphosphate.

Authors:  Xiaohong Wang; Maximilian Ackermann; Meik Neufurth; Shunfeng Wang; Heinz C Schröder; Werner E G Müller
Journal:  Mar Drugs       Date:  2017-05-17       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.